$AURA insider trading
Over the last 12 months, Aura Biosciences insiders reported no purchases and 14 sales totaling $40.1M across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $40.1M 14 events
- Events · 12m
- 14 Form 4 filings, grouped
- Insiders · 12m
- 7 distinct reporters
- 10b5-1 share
- 0% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Gibney Anthony SSee Remarks · O | ▼ Sale | 12,824 | $6.42 | $82K | -4.6% | — |
| May 7, 2026 | Matrix Capital Management Company, LP10% | ▼ Sale | 6,922,870 | $5.64 | $39.0M | -100% | indirect |
| Apr 16, 2026 | Kilroy ConorSee Remarks · O | ▼ Sale | 11,738 | $7.02 | $82K | -5.1% | — |
| Feb 17, 2026 | Kilroy ConorSee Remarks · O | ▼ Sale | 12,079 | $5.05 | $61K | -6.7% | — |
| Feb 17, 2026 | Plavsic MarkChief Technology Officer · O | ▼ Sale | 15,890 | $5.05 | $80K | -8.1% | — |
| Feb 17, 2026 | Hopkins Janet JillChief Medical Officer · O | ▼ Sale | 20,401 | $5.06 | $103K | -8.1% | — |
| Feb 17, 2026 | Elazzouzi AmySenior Vice President, Finance · O | ▼ Sale | 8,549 | $5.06 | $43K | -10.2% | — |
| Feb 17, 2026 | de los Pinos ElisabetSee Remarks · O·D | ▼ Sale | 47,648 | $5.06 | $241K | -10.4% | — |
| Jan 20, 2026 | Elazzouzi AmySenior Vice President, Finance · O | ▼ Sale | 1,581 | $4.86 | $8K | -1.8% | — |
| Jan 20, 2026 | de los Pinos ElisabetSee Remarks · O·D | ▼ Sale | 16,928 | $4.86 | $82K | -3.6% | — |
| Nov 17, 2025 | Hopkins Janet JillChief Medical Officer · O | ▼ Sale | 17,109 | $5.42 | $93K | -6.3% | — |
| Oct 29, 2025 | Elazzouzi AmySenior Vice President, Finance · O | ▼ Sale | 896 | $6.35 | $6K | -1% | — |
| Oct 29, 2025 | de los Pinos ElisabetSee Remarks · O·D | ▼ Sale | 9,049 | $6.35 | $57K | -1.9% | — |
| Oct 16, 2025 | Plavsic MarkChief Technology Officer · O | ▼ Sale | 12,169 | $6.35 | $77K | -5.8% | — |
| Aug 18, 2025 | Elazzouzi AmySenior Vice President, Finance · O | ▼ Sale | 7,722 | $6.7 | $52K | -8.2% | — |
Every $AURA filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Aura Biosciences filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $AURA feed.